Simulations Plus (NASDAQ:SLP) Stock Rating Reaffirmed by Craig Hallum

Simulations Plus (NASDAQ:SLP)‘s stock had its “buy” rating reissued by analysts at Craig Hallum in a research note issued to investors on Wednesday, Benzinga reports. They presently have a $56.00 price objective on the technology company’s stock. Craig Hallum’s price objective points to a potential upside of 40.39% from the stock’s current price.

A number of other research analysts also recently commented on SLP. William Blair initiated coverage on shares of Simulations Plus in a research note on Friday, June 28th. They set an “outperform” rating on the stock. Oppenheimer increased their price objective on shares of Simulations Plus from $55.00 to $65.00 and gave the company an “outperform” rating in a research note on Thursday, June 13th.

Simulations Plus Trading Down 14.9 %

Shares of SLP stock opened at $39.89 on Wednesday. The company has a market capitalization of $797.40 million, a PE ratio of 75.26 and a beta of 0.72. The firm has a fifty day simple moving average of $47.56 and a 200-day simple moving average of $44.12. Simulations Plus has a twelve month low of $32.69 and a twelve month high of $52.69.

Simulations Plus (NASDAQ:SLP) last announced its earnings results on Tuesday, July 2nd. The technology company reported $0.19 earnings per share for the quarter, beating the consensus estimate of $0.15 by $0.04. The business had revenue of $18.54 million during the quarter, compared to the consensus estimate of $17.92 million. Simulations Plus had a net margin of 14.36% and a return on equity of 7.80%. The business’s quarterly revenue was up 14.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.20 earnings per share. Equities research analysts predict that Simulations Plus will post 0.55 EPS for the current year.

Insider Transactions at Simulations Plus

In other news, Director Walter S. Woltosz sold 20,000 shares of the firm’s stock in a transaction dated Monday, July 1st. The shares were sold at an average price of $46.71, for a total value of $934,200.00. Following the transaction, the director now directly owns 3,540,857 shares in the company, valued at approximately $165,393,430.47. The transaction was disclosed in a legal filing with the SEC, which is available at this link. In related news, Director Daniel L. Weiner sold 750 shares of the stock in a transaction dated Friday, June 28th. The shares were sold at an average price of $49.32, for a total value of $36,990.00. Following the sale, the director now owns 7,009 shares of the company’s stock, valued at approximately $345,683.88. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Walter S. Woltosz sold 20,000 shares of the stock in a transaction dated Monday, July 1st. The stock was sold at an average price of $46.71, for a total transaction of $934,200.00. Following the completion of the sale, the director now directly owns 3,540,857 shares in the company, valued at approximately $165,393,430.47. The disclosure for this sale can be found here. In the last three months, insiders have sold 44,500 shares of company stock worth $2,072,198. 20.90% of the stock is currently owned by insiders.

Institutional Trading of Simulations Plus

A number of large investors have recently modified their holdings of the company. Conestoga Capital Advisors LLC increased its stake in Simulations Plus by 12.5% during the 4th quarter. Conestoga Capital Advisors LLC now owns 2,259,176 shares of the technology company’s stock valued at $101,098,000 after buying an additional 251,299 shares during the period. Vanguard Group Inc. increased its stake in Simulations Plus by 1.1% during the 1st quarter. Vanguard Group Inc. now owns 1,135,105 shares of the technology company’s stock valued at $46,710,000 after buying an additional 12,636 shares during the period. Ranger Investment Management L.P. increased its stake in Simulations Plus by 1.4% during the 4th quarter. Ranger Investment Management L.P. now owns 931,132 shares of the technology company’s stock valued at $41,668,000 after buying an additional 12,505 shares during the period. Wasatch Advisors LP increased its stake in Simulations Plus by 36.5% during the 1st quarter. Wasatch Advisors LP now owns 381,693 shares of the technology company’s stock valued at $15,707,000 after buying an additional 102,135 shares during the period. Finally, Kennedy Capital Management LLC increased its stake in Simulations Plus by 3.2% during the 1st quarter. Kennedy Capital Management LLC now owns 229,439 shares of the technology company’s stock valued at $9,441,000 after buying an additional 7,077 shares during the period. Institutional investors and hedge funds own 78.08% of the company’s stock.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.